Skip to main content
TipRanks
Go Ultimate75% OFF

Glenn Tate Insider Profile

4 Followers

Glenn Tate, Senior Officer at Medexus Pharmaceuticals Inc, holds 71.12K shares in Medexus Pharmaceuticals Inc (Ticker: TSE:MDP). Most recently, Glenn Tate Bought 10,000 shares of Medexus Pharmaceuticals Inc on Sep 22, 2022 for an estimated value of C$11.90K.

Glenn Tate's Trading History

MDP
Medexus Pharmaceuticals Inc
Sep 22, 2022Senior OfficerInformative Buy11.90KC$386.16K
TSE:MDP
Insider Shares: 71.12K (35.65%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Sep 22, 2022Informative BuyC$11.90K10,000C$1.19+181.80%―
Dec 30, 2021Uninformative SellC$0.0015,774C$0.00――
Aug 20, 2021Informative Buy$12.29K5,708$2.15-7.20%―
Jun 29, 2021Informative Buy$15.39K2,600$5.92-72.70%―
Jun 23, 2021Informative Buy$14.71K2,494$5.90-72.40%―

You May Also Like

Glenn Tate insider profile FAQ

What is the percentage of profitable transactions made by Glenn Tate?
The percentage of profitable transactions made by Glenn Tate is 20%.
What is the average return per transaction made by Glenn Tate?
The average return per transaction made by Glenn Tate is -4.50%.
What stocks does Glenn Tate hold?
Glenn Tate holds: TSE:MDP stocks.
What was Glenn Tate’s latest transaction?
Glenn Tate’s latest transaction was an Informative Buy of C$11.90K.
What was Glenn Tate's most profitable transaction?
Glenn Tate’s most profitable transaction was an Informative Buy of TSE:MDP stock on September 22, 2022. The return on the trade was 181.80%.
What is Glenn Tate's role in Medexus Pharmaceuticals Inc?
Glenn Tate's role in Medexus Pharmaceuticals Inc is Senior Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.